orantinib has been researched along with zearalenone in 1 studies
| Studies (orantinib) | Trials (orantinib) | Recent Studies (post-2010) (orantinib) | Studies (zearalenone) | Trials (zearalenone) | Recent Studies (post-2010) (zearalenone) |
|---|---|---|---|---|---|
| 110 | 19 | 36 | 2,356 | 41 | 1,352 |
| Protein | Taxonomy | orantinib (IC50) | zearalenone (IC50) |
|---|---|---|---|
| 90-kda heat shock protein beta HSP90 beta, partial | Homo sapiens (human) | 2.402 | |
| PTK2B protein tyrosine kinase 2 beta | Homo sapiens (human) | 6.922 | |
| heat shock protein HSP 90-alpha isoform 2 | Homo sapiens (human) | 2.402 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-awar, R; Fladd, C; Jiang, C; Nguyen, L; Prakesch, M; Rotin, D; Trzcinska-Daneluti, AM; Uehling, D | 1 |
1 other study(ies) available for orantinib and zearalenone
| Article | Year |
|---|---|
Use of kinase inhibitors to correct ΔF508-CFTR function.
Topics: Animals; Benzazepines; Cell Line; Cricetinae; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Dogs; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; HEK293 Cells; Humans; Indoles; Ion Transport; Membrane Proteins; Oxindoles; Propionates; Protein Kinase Inhibitors; Protein Transport; Protein-Tyrosine Kinases; Pyrroles; Receptor, Fibroblast Growth Factor, Type 1; Receptors, Platelet-Derived Growth Factor; Receptors, Vascular Endothelial Growth Factor; RNA Interference; RNA, Small Interfering; Sequence Deletion; Signal Transduction; Zearalenone | 2012 |